07:16 AM EST, 03/07/2024 (MT Newswires) -- Stevanato Group (STVN) reported Q4 adjusted earnings Thursday of 0.18 euro ($0.20) per diluted share, down from 0.19 euro a year earlier.

Analysts polled by Capital IQ expected 0.19 euro.

Revenue for the quarter ended Dec. 31 was 320.6 million euro, up from 292.1 million euro a year earlier.

Analysts polled by Capital IQ expected 326.9 million.

For full-year 2024, the drug delivery and diagnostic company said it expects adjusted diluted EPS of 0.62 euro to 0.66 euro, on revenue of 1.18 billion euro to 1.21 billion euro. Analysts surveyed by Capital IQ are expecting adjusted EPS of 0.66 euro on revenue of 1.22 billion euro.